Conde I - Search Results

1

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.

López-Riera M, Conde I, Tolosa L, Zaragoza Á, Castell JV, Gómez-Lechón MJ, Jover R. López-Riera M, et al. Among authors: conde i. Front Pharmacol. 2017 Jan 25;8:3. doi: 10.3389/fphar.2017.00003. eCollection 2017. Front Pharmacol. 2017. PMID: 28179883 Free PMC article.

2

Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer.

Bakewell S, Conde I, Fallah Y, McCoy M, Jin L, Shajahan-Haq AN. Bakewell S, et al. Among authors: conde i. Cancers (Basel). 2020 Sep 16;12(9):2647. doi: 10.3390/cancers12092647. Cancers (Basel). 2020. PMID: 32947941 Free PMC article.

3

Competency of different cell models to predict human hepatotoxic drugs.

Gómez-Lechón MJ, Tolosa L, Conde I, Donato MT. Gómez-Lechón MJ, et al. Among authors: conde i. Expert Opin Drug Metab Toxicol. 2014 Nov;10(11):1553-68. doi: 10.1517/17425255.2014.967680. Epub 2014 Oct 9. Expert Opin Drug Metab Toxicol. 2014. PMID: 25297626 Review.

4

Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

Thiel C, Cordes H, Conde I, Castell JV, Blank LM, Kuepfer L. Thiel C, et al. Among authors: conde i. Arch Toxicol. 2017 Feb;91(2):865-883. doi: 10.1007/s00204-016-1723-x. Epub 2016 May 9. Arch Toxicol. 2017. PMID: 27161439 Free PMC article.

5

Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems.

Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Fernández-Murga ML, et al. Among authors: conde i. Food Chem Toxicol. 2018 Oct;120:196-212. doi: 10.1016/j.fct.2018.07.017. Epub 2018 Jul 7. Food Chem Toxicol. 2018. PMID: 29990576 Review.

6

Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers.

López-Riera M, Conde I, Quintas G, Pedrola L, Zaragoza Á, Perez-Rojas J, Salcedo M, Benlloch S, Castell JV, Jover R. López-Riera M, et al. Among authors: conde i. Sci Rep. 2018 Jul 13;8(1):10606. doi: 10.1038/s41598-018-28854-4. Sci Rep. 2018. PMID: 30006517 Free PMC article.

7

A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.

López-Riera M, Conde I, Castell JV, Jover R. López-Riera M, et al. Among authors: conde i. Toxicol Sci. 2020 Feb 1;173(2):229-243. doi: 10.1093/toxsci/kfz138. Toxicol Sci. 2020. PMID: 31198949

8

Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.

Petrov PD, Fernández-Murga L, Conde I, Martínez-Sena T, Guzmán C, Castell JV, Jover R. Petrov PD, et al. Among authors: conde i. Arch Toxicol. 2020 Feb;94(2):589-607. doi: 10.1007/s00204-019-02643-y. Epub 2020 Jan 1. Arch Toxicol. 2020. PMID: 31894354

9

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes.

Quintás G, Martínez-Sena T, Conde I, Pareja Ibars E, Kleinjans J, Castell JV. Quintás G, et al. Among authors: conde i. Arch Toxicol. 2021 Sep;95(9):3049-3062. doi: 10.1007/s00204-021-03114-z. Epub 2021 Jul 17. Arch Toxicol. 2021. PMID: 34274980 Free PMC article.

10

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.

Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, Cabello MR, Robles-Diaz M, Sanabria-Cabrera J, Sanjuan-Jimenez R, Ortega-Alonso A, García-Muñoz B, Moreno I, Jimenez-Perez M, Fernandez MC, Ginés P, Prieto M, Conde I, Hallal H, Soriano G, Roman E, Castiella A, Blanco-Reina E, Montes MR, Quiros-Cano M, Martin-Reyes F, Lucena MI, Andrade RJ; Spanish DILI Registry. Medina-Caliz I, et al. Among authors: conde i. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1495-1502. doi: 10.1016/j.cgh.2017.12.051. Epub 2018 Jan 4. Clin Gastroenterol Hepatol. 2018. PMID: 29307848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page